Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;105(6):446-457.
doi: 10.1002/cyto.a.24838. Epub 2024 Apr 16.

A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus

Veridiane M Pscheidt  1 , Priscila Oliveira de Souza  1 , Tiago Fazolo  1 , José Luiz Proença Modena  2 , Camila Simeoni  2 , Daniel Teixeira  2 , Natália Brunetti Silva  2 , Karina Bispo Dos Santos  2 , Luiz Rodrigues Júnior  1 , Cristina Bonorino  1   3
Affiliations
Free article

A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus

Veridiane M Pscheidt et al. Cytometry A. 2024 Jun.
Free article

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 virus has highlighted the need for serological assays that can accurately evaluate the neutralizing efficiency of antibodies produced during infection or induced by vaccines. However, conventional assays often require the manipulation of live viruses on a level-three biosafety (BSL3) facility, which presents practical and safety challenges. Here, we present a novel, alternative assay that measures neutralizing antibodies (NAbs) against SARS-CoV-2 in plasma using flow cytometry. This assay is based on antibody binding to the S protein and has demonstrated precision in both intra- and inter-assay measurements at a dilution of 1:50. The cut-off was determined using Receiver Operating Characteristic (ROC) analysis and the value of 36.01% has shown high sensitivity and specificity in distinguishing between pre-pandemic sera, COVID-19 patients, and vaccinated individuals. The efficiency significantly correlates with the gold standard test, PRNT. Our new assay offers a safe and efficient alternative to conventional assays for evaluating NAbs against SARS-CoV-2.

Keywords: COVID‐19; PRNT; S protein; flow cytometry.

PubMed Disclaimer

References

REFERENCES

    1. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person‐to‐person transmission: a study of a family cluster. Lancet. 2020;395:514–523.
    1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273.
    1. WHO. WHO Director‐General's opening remarks at the media briefing on COVID‐19 – 11 March 2020. 2020.
    1. Hu Y, Wen J, Tang L, Zhang H, Zhang X, Li Y, et al. The M protein of SARS‐CoV: basic structural and immunological properties. Genom Proteom Bioinformat/Beijing Genom Inst. 2003;1:118–130.
    1. Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS‐CoV‐2 in a COVID‐19 recovered patient cohort and their implications. SSRN Electron J. 2020;152(1&2):82‐87.

Substances

LinkOut - more resources